1. Home
  2. RVPHW vs L Comparison

RVPHW vs L Comparison

Compare RVPHW & L Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPHW
  • L
  • Stock Information
  • Founded
  • RVPHW N/A
  • L 1969
  • Country
  • RVPHW United States
  • L United States
  • Employees
  • RVPHW 15
  • L N/A
  • Industry
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • L Property-Casualty Insurers
  • Sector
  • RVPHW Health Care
  • L Finance
  • Exchange
  • RVPHW Nasdaq
  • L Nasdaq
  • Market Cap
  • RVPHW N/A
  • L 18.2B
  • IPO Year
  • RVPHW 2018
  • L N/A
  • Fundamental
  • Price
  • RVPHW $0.14
  • L $83.58
  • Analyst Decision
  • RVPHW
  • L
  • Analyst Count
  • RVPHW 0
  • L 0
  • Target Price
  • RVPHW N/A
  • L N/A
  • AVG Volume (30 Days)
  • RVPHW N/A
  • L 716.9K
  • Earning Date
  • RVPHW N/A
  • L 02-03-2025
  • Dividend Yield
  • RVPHW N/A
  • L 0.30%
  • EPS Growth
  • RVPHW N/A
  • L 29.61
  • EPS
  • RVPHW N/A
  • L 7.53
  • Revenue
  • RVPHW N/A
  • L $17,222,000,000.00
  • Revenue This Year
  • RVPHW N/A
  • L N/A
  • Revenue Next Year
  • RVPHW N/A
  • L N/A
  • P/E Ratio
  • RVPHW N/A
  • L $10.84
  • Revenue Growth
  • RVPHW N/A
  • L 11.57
  • 52 Week Low
  • RVPHW N/A
  • L $68.49
  • 52 Week High
  • RVPHW N/A
  • L $87.45
  • Technical
  • Relative Strength Index (RSI)
  • RVPHW N/A
  • L 41.05
  • Support Level
  • RVPHW N/A
  • L $80.77
  • Resistance Level
  • RVPHW N/A
  • L $84.25
  • Average True Range (ATR)
  • RVPHW 0.00
  • L 1.33
  • MACD
  • RVPHW 0.00
  • L -0.59
  • Stochastic Oscillator
  • RVPHW 0.00
  • L 24.57

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About L Loews Corporation

Loews Corp is a holding company that is supported by a variety of businesses. Its majority revenue generating subsidiary is CNA Financial Corporation, a property and casualty insurance company. CNA's services include risk management, information services, and warranty and claims administration. Loews also maintains an operation of offshore oil and gas drilling rigs through Diamond Offshore Drilling, Inc. The company engages in the transportation and storage of natural gas and natural gas liquids and gathering and processing of natural gas through Boardwalk Pipeline Partners, LP. Loews also operates a chain of hotels.

Share on Social Networks: